In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
about
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanomaClinical trials of immunogene therapy for spontaneous tumors in companion animals.Age-dependent tolerance to an endogenous tumor-associated antigen.Spontaneously occurring tumors of companion animals as models for human cancer.High-efficiency screening of monoclonal antibodies for membrane protein crystallographyGene therapy for malignant liver disease.Large animal models and gene therapy.Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma: an in vitro studyPhase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.IL-12 based gene therapy in veterinary medicine.Transhepatic therapies for metastatic uveal melanoma.Immunotherapy for canine cancer--is it time to go back to the future?Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma.Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up.Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth.Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice.Enhancing antimelanoma immune responses through apoptosis.Survey: immune function and immunotoxicity assessment in dogs.Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
P2860
Q24684238-D6AEBDC8-BE04-4790-A79B-EA84364EE7FBQ27692032-85AA95F1-7276-4261-947B-C021C2369022Q30439993-3C6B61C9-1C57-4D49-B609-73BC1B566006Q33927360-EA748EB6-103B-4A8C-82AE-9AEBF60D9735Q34023852-F0FDB853-5749-4250-9BFD-81982FD739F3Q34534279-2D0B3E82-4F6C-4308-9157-169D13939D4AQ36333340-EF3E9395-7EF0-4171-845F-2B0947DEE4B6Q36474594-5AD7D73D-0CEA-4DA1-BAED-B2CB0B4BE365Q36621492-8D58CFBF-4B51-4D49-92BE-BEE812EEF580Q38061510-3D3ED233-0BFD-4CFA-9562-09D61457F7E6Q38179345-10FB6FBA-E838-425E-8C96-7B6ABFAC47B7Q38363923-0055A336-EBDF-4BFE-8B0D-F81C23FC8006Q39142678-15E1652A-970D-40B0-AD74-A91BB3E343ADQ39260959-14295846-336C-4293-A992-4A36975D8D2CQ39962730-A5C3E9CB-544B-4669-B977-A344AEA7C788Q41729605-BF172E33-9874-48F6-8D45-28140D231C54Q47659517-2A176438-4335-49EC-B648-6502111AA82FQ50984298-7D6B3C77-8233-40B1-AD93-6AA2E56352F9Q52828829-D2E2CBB3-E277-4431-A9C9-E5482F23230DQ53106935-2D1C36B1-DA17-4437-A9AD-101D66991731
P2860
In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@en
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@nl
type
label
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@en
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@nl
prefLabel
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@en
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@nl
P2093
P2860
P356
P1476
In vivo tumor transfection wit ...... dogs with malignant melanoma.
@en
P2093
P2860
P304
P356
10.1172/JCI510
P407
P577
1998-06-01T00:00:00Z